Atlas Trials

A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma

Clinical trial NCT05155020 · TERMINATED

Trial details

NCT number
NCT05155020
Sponsor
Akeso
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2022-02-11
Primary completion
2022-08-05
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.